George Medicines
Phase 3George Medicines - late stage drug development focused on improving the management of non-communicable diseases with single-pill, multi-mechanism combinations of existing medicines.
Founded
2018
Focus
CardiovascularMetabolic
About
George Medicines - late stage drug development focused on improving the management of non-communicable diseases with single-pill, multi-mechanism combinations of existing medicines.
Funding History
2Total raised: $35M
Series A$30MGeorge ClinicalMay 15, 2022
Seed$5MGeorge ClinicalSep 15, 2020
Company Info
TypePrivate
Founded2018
LocationLondon, United Kingdom
StagePhase 3
Contact
Sectors
SIMILAR COMPANIES
Abbexa
Pre-clinical · Cambridge
Accentus Medical
Pre-clinical · Oxford
AbOliGo
Pre-clinical · London
Bigespas
Pre-clinical · London
Actimed Therapeutics
Pre-clinical · London
Is this your company?
Claim your profile to update information, add pipeline data, and connect with investors.
Claim profile